As Paychex has underperformed the broader market over the past year, analysts remain cautious about the stock’s prospects.
Retail sentiment on the stock rose to ‘extremely bullish’ (92/100) from ‘neutral’ (52/100) a week ago. Message volumes rose to ‘extremely high’ levels.
The rally in the world's largest cryptocurrency is showing no signs of slowdown since Donald Trump’s victory in the presidential election spurred excitement about the digital currency. Bitcoin surged...
Adobe ADBE shares have declined 19.4% in the trailing 12 months, underperforming the broader Zacks Computer & Technology sector’s return of 32.9% and the Zacks Computer Software industry’s appreciation...
Puma Biotechnology, Inc. PBYI announced that it has initiated the phase II ALISCA-Breast1 study evaluating its pipeline candidate, alisertib, for the treatment of patients with metastatic breast cancer.The...
Barkin also indicated that businesses are worried about a potential rise in inflation in the wake of President-elect Donald Trump’s potential policies on tariffs and mass deportations
Snowflake SNOW reported third-quarter fiscal 2025 non-GAAP earnings of 20 cents per share, beating the Zacks Consensus Estimate by 33.33%. The figure declined 20% year over year.SNOW’s earnings beat...
Universal Technical Institute, Inc. UTI reported impressive fourth-quarter fiscal 2024 results, with earnings and revenues beating the Zacks Consensus Estimate. On a year-over-year basis, both top and...
McKesson Corporation’s MCK dedicated business focused on supporting the commercialization of cell and gene therapies, InspiroGene, has been selected by Vertex Pharmaceuticals Incorporated VRTX to expand...
/Bio-Techne%20Corp%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Bio-Techne has underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.